Evaluation of ascorbic acid 2-O-alpha-glucoside as vitamin C source : mode of intestinal hydrolysis and absorption following oral administration

Ascorbic acid 2-O-alpha-glucoside (AA-2G) has been reported to have antiscorbutic activity in guinea pigs. The present experiments examined the metabolic fate of AA-2G following ingestion. Oral administration of AA-2G (96 mg) to guinea pigs resulted in a remarkable increase of ascorbic acid in various tissues as well as plasma, but intact AA-2G was detected only in plasma, but intact AA-2G was detected only in plasma and urine in small amounts. The absorption efficiency of AA-2G and ascorbic acid was further determined by using everted gut sacs of rats. Ascorbic acid released from AA-2G on the mucosal side was effectively taken up across intestinal membranes into the serosal side, whereas AA-2G poorly permeated via a passive transport system. The hydrolysis of AA-2G on the mucosal surface of everted gut was completely inhibited by an alpha-glucosidase inhibitor and the hydrolytic activity of a crude membrane extract diminished to one-forth after immunoprecipitation with the antibody specific to maltase. From these results, it is concluded that ingested AA-2G serves as a vitamin C source through the hydrolysis by intestinal membrane-bound alpha-glucosidase, mainly maltase, and the subsequent absorption of released ascorbic acid.

Medienart:

Artikel

Erscheinungsjahr:

1992

Erschienen:

1992

Enthalten in:

Zur Gesamtaufnahme - volume:62

Enthalten in:

International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition - 62(1992), 4 vom: 20., Seite 318-23

Sprache:

Englisch

Beteiligte Personen:

Muto, N [VerfasserIn]
Terasawa, K [VerfasserIn]
Yamamoto, I [VerfasserIn]

Themen:

2V52R0NHXW
Alpha-Glucosidases
Ascorbic Acid
Ascorbic acid 2-O-glucoside
EC 3.2.1.20
Journal Article
PQ6CK8PD0R
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 30.03.1993

Date Revised 30.11.2018

published: Print

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM012723371